CN Patent

CN105380917B — 一种盐酸普拉克索缓释片及其制备方法

Assigned to JIANGSU SHENHUA PHARMACEUTICAL CO Ltd · Expires 2019-01-15 · 7y expired

What this patent protects

本发明公开了一种盐酸普拉克索缓释片及其制备方法。该盐酸普拉克索缓释片通过采用天然高分子黄原胶和阿拉伯胶的组合物为缓释载体基质，能有效调控稳定的血药浓度，减少每天内给药次数，降低盐酸普拉克索对肝肾代谢的损害，本发明盐酸普拉克索缓释片硬度适中，缓释能力强，无药物突释效应。

USPTO Abstract

本发明公开了一种盐酸普拉克索缓释片及其制备方法。该盐酸普拉克索缓释片通过采用天然高分子黄原胶和阿拉伯胶的组合物为缓释载体基质，能有效调控稳定的血药浓度，减少每天内给药次数，降低盐酸普拉克索对肝肾代谢的损害，本发明盐酸普拉克索缓释片硬度适中，缓释能力强，无药物突释效应。

Drugs covered by this patent

Patent Metadata

Patent number
CN105380917B
Jurisdiction
CN
Classification
—
Expires
2019-01-15
Drug substance claim
No
Drug product claim
No
Assignee
JIANGSU SHENHUA PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.